Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E. Rulli
Metronomic Chemotherapy With Oral Vinorelbine (mVNR) and Capecitabine (mCAPE) in Advanced HER2-negative Breast Cancer Patients: Is It a Way to Optimize Disease Control? Final Results of the VICTOR-2 Study
Breast Cancer Research and Treatment
Cancer Research
Oncology
The Impact of DNA Damage Response Gene Polymorphisms on Therapeutic Outcomes in Late Stage Ovarian Cancer
Scientific Reports
Multidisciplinary
Related publications
Capecitabine and Vinorelbine as an All-Oral Chemotherapy in HER2-Negative Locally Advanced and Metastatic Breast Cancer
Breast Care
Surgery
Oncology
Phase II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer
The Internet Journal of Oncology
Phase II Trial of Fulvestrant With Metronomic Capecitabine for Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
Combination of Aromatase Inhibitors With Metronomic Capecitabine: A New Chemoendocrine Treatment for Advanced Breast Cancer
Journal of Cancer Therapy
Metronomic Treatment of Advanced Non-Small-Cell Lung Cancer With Daily Oral Vinorelbine &Ndash; A Phase I Trial
OncoTargets and Therapy
Oncology
Pharmacology
Capecitabine in Combination With Docetaxel in First Line in HER2-Negative Metastatic Breast Cancer: An Observational Study
Pathology and Oncology Research
Medicine
Forensic Medicine
Pathology
Oncology
Cancer Research
Metronomic Chemotherapy in Metastatic Breast Cancer
Novel Research in Sciences
Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer
New England Journal of Medicine
Medicine
A Study of Capecitabine Metronomic Chemotherapy Is Non-Inferior to Conventional Chemotherapy as Maintenance Strategy in Responders After Induction Therapy in Metastatic Colorectal Cancer
Trials
Medicine
Pharmacology
